Do antinuclear antibodies precede systemic lupus?
Aho, K.; Koskela, P.; Mäkitalo, R.; Heliövaara, M.; Palosuo, T.
Duodecim; Laaketieteellinen Aikakauskirja 108(2): 157-160
1992
ISSN/ISBN: 0012-7183 PMID: 1365996 Document Number: 397476
Document emailed within 1 workday
Related Documents
Aho, K.; Koskela, P.; Mäkitalo, R.; Heliövaara, M.; Palosuo, T. 1992: Antinuclear antibodies heralding the onset of systemic lupus erythematosus Journal of Rheumatology 19(9): 1377-1379Xie, H.; Liu, Z.; Zhu, W. 1997: Significance of antinuclear antibodies for the diagnosis and activity of systemic lupus erythematosus Hunan Yi Ke Da Xue Xue Bao 22(2): 177-178
Monegat, J.N.; Joller-Jemelka, H.I.; Grob, P.J. 1974: Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases Schweizerische Medizinische Wochenschrift 104(45): 1614-1623
Smolen, J.S.; Hassfeld, W.; Graninger, W.; Steiner, G. 1990: Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis Clinical and Experimental Rheumatology 8(Suppl 5): 41-44
Meyer, O.; Molta, C.; Bourgeois, P.; Haim, T.; Kahn, M.F. 1990: Profile of antinuclear antibodies in 14 cases of extinct systemic lupus erythematosus for more than 3 years Revue du Rhumatisme et des Maladies Osteo-Articulaires 57(9): 599-603
Novak, S. 2009: Clinical significance of antinuclear antibodies and other serological abnormalities in systemic lupus erythematosus (SLE) Reumatizam 56(2): 22-25
Guzman, L.; Avalos, E.; Ortiz, R.; Gurrola, R.; Lopez, E.; Herrera, R. 1987: Placental abnormalities in systemic lupus erythematosus: in situ deposition of antinuclear antibodies Journal of Rheumatology 14(5): 924-929
Acosta-Mérida, A.; Isenberg, D.A. 2013: Antinuclear antibodies seroconversion in 100 patients with lupus Clinical and Experimental Rheumatology 31(4): 656
Alarcon-Segovia, D.; Fishbein, E. 1975: Patterns of antinuclear antibodies and lupus-activating drugs Journal of Rheumatology 2(2): 167-171
Duc, J.; Perroulaz, G.; Golaz, J.; Campiche, M.; Pécoud, A. 1987: Disseminated lupus erythematosus without antinuclear antibodies or other autoantibodies Schweizerische Medizinische Wochenschrift 117(6): 205-208
Gladman, D.D.; Chalmers, A.; Urowitz, M.B. 1978: Systemic lupus erythematosus with negative LE cells and antinuclear factor Journal of Rheumatology 5(2): 142-147
Blaustein, D.A.; Blaustein, S.A. 1998: Antinuclear antibody negative systemic lupus erythematosus presenting as bilateral facial paralysis Journal of Rheumatology 25(4): 798-800
Bernstein, R.M.; Steigerwald, J.C.; Tan, E.M. 1982: Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis Clinical and Experimental Immunology 48(1): 43-51
Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526
Abdel Gawad, E.R.; Mansour, A.I.; Abdel Aziz, Y.A.; Soliman, A.F.; Fawzy, R.M. 2014: Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy Egyptian Journal of Immunology 21(1): 57-65
D'Cruz, D.P.; Mellor-Pita, S.; Joven, B.; Sanna, G.; Allanson, J.; Taylor, J.; Khamashta, M.A.; Hughes, G.R.V. 2004: Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies Journal of Rheumatology 31(2): 280-285
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
López-Longo, F.J.; Monteagudo, I.; González, C.M.; Moreno, A.C.; Rodríguez Mahou, M.; Grau, R.; Carreño, L. 1998: Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus Journal of Rheumatology 25(9): 1743-1749
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924
Meyer, O.; Abuaf, N.; Cyna, L.; Homberg, J.C.; Kahn, M.F.; Ryckewaert, A. 1987: Anti-mitochondrial type 5 antibodies and anti-cardiolipin antibodies in systemic lupus erythematosus and auto-immune diseases Clinical and Experimental Immunology 69(3): 485-492